Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6280531 | Neuroscience Letters | 2015 | 5 Pages |
Abstract
The levels of allopregnanolone (ALLO), a neurosteroid, in brain and serum are related to severity of depression and anxiety. Steroid 5α-reductase type I is the rate-limiting enzyme in ALLO biosynthesis and plays an important role in control of the ALLO level in mammalian brain. In this study, we examined an epigenetic mechanism for transcriptional regulation of srd5a1, which codes for steroid 5α-reductase type I, using isolation-reared mice. The mRNA level of srd5a1 was decreased in the prefrontal cortex (PFC) in isolation-reared mice. Rearing in social isolation increased methylation of cytosines at â82 and â12 bp downstream of the transcription start site, which are located in a GC box element in the promoter region of srd5a1. Binding of Sp1, a ubiquitous transcription factor, to the GC box was decreased in the promoter region of srd5a1 in the PFC in isolation-reared mice. Site-specific methylation at cytosine â12 of a srd5a1 promoter-luciferase reporter construct, but not that of cytosine â82, downregulated the promoter activity of srd5a1. These findings suggest that transcription of srd5a1 in brain is regulated by environmental factor-induced cytosine methylation in the promoter region. This finding could contribute to development of antidepressant and anxiolytic agents.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Ryota Araki, Shoji Nishida, Yosuke Hiraki, Kinzo Matsumoto, Takeshi Yabe,